FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) (Seqirus, Inc.)
Welcome to the PulseAid listing for the FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) drug offered from Seqirus, Inc.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Seqirus, Inc. |
| NON-PROPRIETARY NAME: | A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus), A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 – like virus), B/Utah/9/2014 (a B/Phuket/3073/2013-like virus), B/Ho |
| SUBSTANCE NAME: | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACT |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-07-01 |
| END MARKETING DATE: | 2018-06-30 |
FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) VACCINE Details:
| Item Description | FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) from Seqirus, Inc. |
| LABELER NAME: | Seqirus, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
| START MARKETING DATE: | 2017-07-01 |
| END MARKETING DATE: | 2018-06-30 |
| PRODUCT ID: | 70461-201_b1eda076-5bf4-4fd9-8a66-c106b99633ad |
| PRODUCT NDC: | 70461-201 |
| APPLICATION NUMBER: | BLA125408 |
Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACT Pharmaceutical Manufacturers / Labelers:
